Loading…

The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases

Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 ( ) in non-cancerous diseases with a speci...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2019-02, Vol.20 (3), p.627
Main Authors: Prinz, Felix, Kapeller, Anita, Pichler, Martin, Klec, Christiane
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63
cites cdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63
container_end_page
container_issue 3
container_start_page 627
container_title International journal of molecular sciences
container_volume 20
creator Prinz, Felix
Kapeller, Anita
Pichler, Martin
Klec, Christiane
description Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 ( ) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis, 's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes. expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate 's capability to be a therapeutic target for non-cancerous diseases.
doi_str_mv 10.3390/ijms20030627
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6387324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2332023849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</originalsourceid><addsrcrecordid>eNpdkc1LAzEUxIMotlZvnmXBiwdXk7w02b0IpdYPLBWknkM2m7Ypu0ndbAX_eyOtpXrKY_LL8CaD0DnBNwA5vrXLOlCMAXMqDlCXMEpTjLk43Js76CSEJcYUaD8_Rh3AggjCsy56mS5M8lyvKqtVa70LiZ8lbdTG3s2TiXfp0Jc2jm-TQTIZDaYksW6jK6dN49chubfBqGDCKTqaqSqYs-3ZQ-8Po-nwKR2_Pj4PB-NUM0LbFJTifc0yWkIGmHBa5FAoJoTql9oUAiAKpcgyljFNGRGlKAvGuMG5xsRw6KG7je9qXdQmvnFtoyq5amytmi_plZV_b5xdyLn_lBwyAZRFg6utQeM_1ia0srZBm6pSzsRAkhKR9xkGTiJ6-Q9d-nXjYjxJAWj80YzlkbreULrxITRmtluGYPnTktxvKeIX-wF28G8t8A1JR4sx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2332023849</pqid></control><display><type>article</type><title>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Prinz, Felix ; Kapeller, Anita ; Pichler, Martin ; Klec, Christiane</creator><creatorcontrib>Prinz, Felix ; Kapeller, Anita ; Pichler, Martin ; Klec, Christiane</creatorcontrib><description>Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 ( ) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis, 's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes. expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate 's capability to be a therapeutic target for non-cancerous diseases.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms20030627</identifier><identifier>PMID: 30717168</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adenosine ; Breast cancer ; Cancer ; Carcinogenesis ; Carcinogens ; Cytoplasm ; Editing ; Gene expression ; Hepatocellular carcinoma ; Immune response ; Interleukin 8 ; Liver cancer ; Lung cancer ; MicroRNAs ; Neurodegeneration ; Non-coding RNA ; Ovarian cancer ; Physiology ; Prostate ; Prostate cancer ; Proteins ; Retention ; Review ; Stem cells ; Transcription</subject><ispartof>International journal of molecular sciences, 2019-02, Vol.20 (3), p.627</ispartof><rights>2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</citedby><cites>FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</cites><orcidid>0000-0003-0195-8280 ; 0000-0002-8701-9462</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2332023849/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2332023849?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30717168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prinz, Felix</creatorcontrib><creatorcontrib>Kapeller, Anita</creatorcontrib><creatorcontrib>Pichler, Martin</creatorcontrib><creatorcontrib>Klec, Christiane</creatorcontrib><title>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 ( ) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis, 's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes. expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate 's capability to be a therapeutic target for non-cancerous diseases.</description><subject>Adenosine</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Carcinogenesis</subject><subject>Carcinogens</subject><subject>Cytoplasm</subject><subject>Editing</subject><subject>Gene expression</subject><subject>Hepatocellular carcinoma</subject><subject>Immune response</subject><subject>Interleukin 8</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>MicroRNAs</subject><subject>Neurodegeneration</subject><subject>Non-coding RNA</subject><subject>Ovarian cancer</subject><subject>Physiology</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>Proteins</subject><subject>Retention</subject><subject>Review</subject><subject>Stem cells</subject><subject>Transcription</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1LAzEUxIMotlZvnmXBiwdXk7w02b0IpdYPLBWknkM2m7Ypu0ndbAX_eyOtpXrKY_LL8CaD0DnBNwA5vrXLOlCMAXMqDlCXMEpTjLk43Js76CSEJcYUaD8_Rh3AggjCsy56mS5M8lyvKqtVa70LiZ8lbdTG3s2TiXfp0Jc2jm-TQTIZDaYksW6jK6dN49chubfBqGDCKTqaqSqYs-3ZQ-8Po-nwKR2_Pj4PB-NUM0LbFJTifc0yWkIGmHBa5FAoJoTql9oUAiAKpcgyljFNGRGlKAvGuMG5xsRw6KG7je9qXdQmvnFtoyq5amytmi_plZV_b5xdyLn_lBwyAZRFg6utQeM_1ia0srZBm6pSzsRAkhKR9xkGTiJ6-Q9d-nXjYjxJAWj80YzlkbreULrxITRmtluGYPnTktxvKeIX-wF28G8t8A1JR4sx</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Prinz, Felix</creator><creator>Kapeller, Anita</creator><creator>Pichler, Martin</creator><creator>Klec, Christiane</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0195-8280</orcidid><orcidid>https://orcid.org/0000-0002-8701-9462</orcidid></search><sort><creationdate>20190201</creationdate><title>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</title><author>Prinz, Felix ; Kapeller, Anita ; Pichler, Martin ; Klec, Christiane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenosine</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Carcinogenesis</topic><topic>Carcinogens</topic><topic>Cytoplasm</topic><topic>Editing</topic><topic>Gene expression</topic><topic>Hepatocellular carcinoma</topic><topic>Immune response</topic><topic>Interleukin 8</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>MicroRNAs</topic><topic>Neurodegeneration</topic><topic>Non-coding RNA</topic><topic>Ovarian cancer</topic><topic>Physiology</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>Proteins</topic><topic>Retention</topic><topic>Review</topic><topic>Stem cells</topic><topic>Transcription</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prinz, Felix</creatorcontrib><creatorcontrib>Kapeller, Anita</creatorcontrib><creatorcontrib>Pichler, Martin</creatorcontrib><creatorcontrib>Klec, Christiane</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prinz, Felix</au><au>Kapeller, Anita</au><au>Pichler, Martin</au><au>Klec, Christiane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>20</volume><issue>3</issue><spage>627</spage><pages>627-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 ( ) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis, 's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes. expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate 's capability to be a therapeutic target for non-cancerous diseases.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>30717168</pmid><doi>10.3390/ijms20030627</doi><orcidid>https://orcid.org/0000-0003-0195-8280</orcidid><orcidid>https://orcid.org/0000-0002-8701-9462</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2019-02, Vol.20 (3), p.627
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6387324
source PMC (PubMed Central); Publicly Available Content (ProQuest)
subjects Adenosine
Breast cancer
Cancer
Carcinogenesis
Carcinogens
Cytoplasm
Editing
Gene expression
Hepatocellular carcinoma
Immune response
Interleukin 8
Liver cancer
Lung cancer
MicroRNAs
Neurodegeneration
Non-coding RNA
Ovarian cancer
Physiology
Prostate
Prostate cancer
Proteins
Retention
Review
Stem cells
Transcription
title The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-05T21%3A42%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Implications%20of%20the%20Long%20Non-Coding%20RNA%20NEAT1%20in%20Non-Cancerous%20Diseases&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Prinz,%20Felix&rft.date=2019-02-01&rft.volume=20&rft.issue=3&rft.spage=627&rft.pages=627-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms20030627&rft_dat=%3Cproquest_pubme%3E2332023849%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2332023849&rft_id=info:pmid/30717168&rfr_iscdi=true